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Abstract
Background: Salmonella enteritidis is suggested to translocate in the small intestine. In vivo it
induces gene expression changes in the ileal mucosa and Peyer's patches. Stimulation of Salmonella
translocation by dietary prebiotics fermented in colon suggests involvement of the colon as well.
However, effects of Salmonella on colonic gene expression in vivo are largely unknown. We aimed
to characterize time dependent Salmonella-induced changes of colonic mucosal gene expression in
rats using whole genome microarrays. For this, rats were orally infected with Salmonella enteritidis
to mimic a foodborne infection and colonic gene expression was determined at days 1, 3 and 6
post-infection (n = 8 rats per time-point). As fructo-oligosaccharides (FOS) affect colonic
physiology, we analyzed colonic mucosal gene expression of FOS-fed versus cellulose-fed rats
infected with Salmonella in a separate experiment. Colonic mucosal samples were isolated at day 2
post-infection.
Results: Salmonella affected transport (e.g. Chloride channel calcium activated 6, H+/K+
transporting Atp-ase), antimicrobial defense (e.g. Lipopolysaccharide binding protein, Defensin 5
and phospholipase A2), inflammation (e.g. calprotectin), oxidative stress related genes (e.g. Dual
oxidase 2 and Glutathione peroxidase 2) and Proteolysis (e.g. Ubiquitin D and Proteosome subunit
beta type 9). Furthermore, Salmonella translocation increased serum IFNγ and many interferon-
related genes in colonic mucosa. The gene most strongly induced by Salmonella infection was
Pancreatitis Associated Protein (Pap), showing >100-fold induction at day 6 after oral infection.
Results were confirmed by Q-PCR in individual rats. Stimulation of Salmonella translocation by
dietary FOS was accompanied by enhancement of the Salmonella-induced mucosal processes, not
by induction of other processes.
Conclusion: We conclude that the colon is a target tissue for Salmonella, considering the abundant
changes in mucosal gene expression.
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Foodborne infections cause a major burden on public
health services and represent significant costs in many
countries. Salmonella infection is one of the most com-
mon and widely distributed foodborne diseases and can
be severe in the young, the elderly and patients with weak-
ened immunity. Salmonella enteritidis is the most fre-
quently isolated serotype, causing gastroenteritis in most
humans and systemic infection in a subpopulation [1,2].
The precise mechanisms of Salmonella-host interaction in
vivo at early time points after infection are not well
known. Insight in pathogen-induced host processes in vivo
could help to design therapeutic or nutritional strategies
for infection prevention. An approach to investigate the
effects of a pathogen on host target cells is the use of
microarrays that contain the whole genome of the host.
This broad approach can reveal biological processes
affected by the pathogen. The rat is a good model to study
Salmonella enteritidis-induced host processes, since salmo-
nellosis in the rat shares many features of human disease
[3]. Besides gastroenteritis, a self-limiting systemic infec-
tion is observed in rats. The ileum is thought to be the
main site of Salmonella invasion in both humans and rats
[4]. For this reason we have previously studied Salmonella-
induced gene expression in the ileum of rats. This study
showed that Salmonella affects only a small number of
genes at early time points post-infection [5]. Carbohy-
drate transport, antimicrobial defense and detoxification
were the main affected biological processes. At later time
points large numbers of inflammation genes were found
to be up-regulated in the ileal mucosa. The colon mucosa
is supposed to be protected from Salmonella colonization
by the abundant intestinal microflora. Pathogens entering
the colon have to compete for nutrients and binding
places with the endogenous flora. However, biopsies
taken from humans during an infection with nontyphoid
Salmonella setorypes suggest that the colon is involved in
Salmonella infections [6-8]. As most studies focus on the
ileum, which is thought to be the most likely site of trans-
location, only little information is available on Salmonella
translocation in the large intestine [9]. Besides indications
from studies on biopsies, we have another reason to sus-
pect colonic involvement in Salmonella infection pathol-
ogy. We have shown earlier that diets supplemented with
prebiotics such as fructo-oligosaccharides (FOS), lactulose
and inulin consistently increased intestinal Salmonella
translocation in rats [10-13]. As fermentation of FOS, and
other prebiotics, occurs in cecum and colon and is very
limited in the ileum of humans [14] and rats [15], it is
unlikely that prebiotics facilitated translocation of Salmo-
nella at that particular site. This is supported by the
absence of ileal inflammation in FOS-fed and Salmonella-
infected rats in contrast to profound cecal and colonic
inflammation [11]. To extend the current limited evi-
dence indicating colonic involvement in Salmonella infec-
tion, we used transcriptional profiling to investigate genes
and biological processes in the rat colonic mucosa
affected by Salmonella. We first studied colonic mucosal
gene expression responses at days 1, 3 and 6 after oral Sal-
monella infection of rats using whole genome microarrays
and Q-PCR. In a second infection experiment, we studied
whether the increased translocation of Salmonella by die-
tary FOS was reflected by amplification of Salmonella-
induced gene expression changes in the colon.
Results
Time course infection study
General infection characteristics
In agreement with previous studies, food consumption
and growth of the Wistar rats were not affected by Salmo-
nella infection [16]. Salmonella translocation to mesenteric
lymph nodes was observed at days 1, 3 and 6 (table 1).
This implies that at day 1, Salmonella has already crossed
the intestinal barrier. In agreement with previous studies
[16,17], Salmonella was detected in the spleen at days 3
and 6 and in the liver at day 6 (table 1). Urinary NOx
excretion, a parameter of systemic infection, was found to
be increased from day 3 onwards (figure 1a).
Salmonella-induced processes in colon mucosa
To identify Salmonella-regulated processes, microarray-
based gene expression profiling of colonic mucosa at days
1, 3 and 6 days p.i. was performed. The arrays contained
44000 spots of which 32783 spots exceeded >2 times the
Sum of urinary nitrate and nitrite (NOx) excretion in the non-in ected (❍), infected (■) groups of the time coursinfection stud (A)Figure 1
Sum of urinary nitrate and nitrite (NOx) excretion in the 
non-infected (❍), infected (■) groups of the time course 
infection study (A). And the urinary NOx excretion in the 
cellulose infected (■) and in the fructo-oligosaccharide (FOS) 
infected (▲) groups in the dietary infection study (B). 
Infected rats were orally challenged with S. enteritidis on day 
0. Results are expressed as mean ± SEM (n = 8 in the time 
course infection study and n = 6 in the dietary infection 
study). * p < 0.05.
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BMC Microbiology 2007, 7:84 http://www.biomedcentral.com/1471-2180/7/84background value and were included in the analysis. Sal-
monella changed the expression of 330 genes >2-fold at
least at one of the three time points studied. At days 1 and
3 p.i. comparable numbers of genes (70 and 57 genes,
respectively) were affected by Salmonella infection in com-
parison with non-infected rats, while at day 6 approxi-
mately four times more genes were affected (figure 2).
This corresponded with progression of the infection as
observed by the organ cultures and urinary NOx excretion
as mentioned above. At all time points studied, most
genes showed increased expression upon Salmonella infec-
tion, whereas only a small percentage of total regulated
genes were down-regulated (10% at day 1, 27% at day 3,
5% at day 6 figure 2). The genes that changed more than
2-fold at any time point (FC > 2 infected/non-infected)
were classified into biological processes according to gene
ontology terminology [18,19]. Not all genes are anno-
tated to GO processes. Forty percent of the genes on the
array were annotated to GO processes. Therefore we man-
ually supplemented the significant processes (p < 0.001)
with the remaining significant genes using biological
databases and scientific literature. To prevent the occur-
rence of false positive genes, and over-interpretation of
biological processes affected by Salmonella, we focused on
biological processes with at least three genes exceeding the
cut-off FC > 2.0. Additionally, we observed that the genes
within one biological process showed comparable pat-
terns of expression (table 2), which strongly indicates that
these processes are truly affected by Salmonella.
We focused on the early Salmonella-induced gene expres-
sion changes occurring at days 1 and 3 p.i. Presumably,
these early modulated genes are more related to Salmo-
nella-induced primary changes than gene expression at
day 6 which is a secondary result of Salmonella-induced
inflammation. Genes affected >2-fold on day 1 and/or
day 3 p.i. that could be related to a biological process are
shown in table 2. The biological processes that contained
3 or more modulated genes were transport, oxidative
stress, immune response, antimicrobial defense, inflam-
matory response, interferon pathways and proteolysis. For
more insight into these processes, genes that changed >2-
fold at day 6 p.i. and also showing a >1.5-fold induction
at day 1 or 3 p.i. were also added to this table. Genes that
changed >2-fold on day 6 p.i. only are shown in Addi-
tional File 1. The gene most affected by Salmonella infec-
tion in the colon was pancreatitis associated protein
(Pap), showing 11, 45 and 114 fold induction at days 1, 3
and 6 respectively. Seventy genes changed >2-fold at day
1 p.i., of these genes 7 encoded for transporters and 5
genes encoded for immune response proteins (table 2). At
day 3 p.i., 57 genes showed FC > 2, again including genes
encoding for immune response proteins. Induced expres-
sion of Interleukin 1β and 1α indicates activation of an
inflammatory response. Induction of dual oxidase 2 and
glutathione peroxidase 2 suggest oxidative stress in the
colonic mucosa. At day 6 more than 200 genes were
induced more than 2-fold in infected mucosa compared
with non-infected mucosa (Additional File 1). Most of
these genes were related to immune and inflammatory
responses. Processes related to inflammation-induced
damage and repair, such as connective tissue remodeling
and chemo-attraction also showed clear induction at day
6 p.i. To exclude the possibility that the observed changes
were due to cellular changes of the mucosa, we analyzed
expression differences of cell-type specific genes [20,21]
(Additional File 2). As transporters are most likely
expressed by enterocytes [22], we examined expression of
enterocyte specific genes (Fabp2, Vil2, Alpi2). These genes
showed diverse regulation, indicating that the increased
expression of transporters at day 1 is not due to altered
enterocyte composition in the mucosal samples. A similar
observation was found for Goblet cell specific genes
(Muc2, Muc3, Tff1, Tff3) and Paneth cell specific genes
(RD-5 and Pla2g2a). Expression of leukocyte specific
genes was not altered at early timepoint, a mild increase
was observed at day 6 p.i. Together this indicated that the
observed Salmonella induced gene expression changes did
Table 1: Viable Salmonella counts in feces, mesenteric lymph 
nodes, spleen, and liver of rats 1, 3 and 6 days post infection
Salmonella (logCFU/g)a
Control Day 1 p.i. Day 3 p.i. Day 6 p.i.
Feces N.D. 7.22 ± 0.19 5.92 ± 0.24 6.04 ± 0.32
MLN N.D. 3.38 ± 0.43 5.85 ± 0.13 5.44 ± 0.05
Spleen N.D. N.D 3.20 ± 0.33 3.49 ± 0.05
Liver N.D. N.D N.D 2.45 ± 0.12
a The rats were orally infected with 3 × 109colony-forming units of S. 
enteritidis or control treated. Salmonella counts are expressed in log 
values as means ± SEM (n = 8). N.D. = not detected.
The number of differentially expressed genes with a fold change greater than 2 in colon mucosa of rats at days 1, 3 or 6 after o al infection wi h Salmon lla or con rol re tmentFigur  2
The number of differentially expressed genes with a fold 
change greater than 2 in colon mucosa of rats at days 1, 3 or 
6 after oral infection with Salmonella or control treatment.
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Table 2: Processes regulated in colon by Salmonella at days 1, 3 and 6 after oral Salmonella infection
Gene Name Gene 
symbol
Sequence ID Fold Change infected vs non-infected rats on 
different days p.i.
Time course infection studya Dietary infection 
studyb
Day 1 Day 3 Day 6 Day 2
Transport
Ion transport
Chloride channel calcium activated 6 Clca6 NM_201419 2,3 2,2 3,7 2,3
Calcium channel, voltage-dependent, alpha 1I subunit Cacna1i NM_020084 2,2 1,5 - 1,2
Solute carrier family 4, member 1 (Slc4a1), anion exchanger Slc4a1 NM_012651 2,0 1,7 - 1,0
Atp-ase, H+/K+ transporting, nongastric, alpha polypeptide Atp12a NM_133517 2,8 - 2,0 1,1
Solute carrier family 20 (phosphate transporter), member 1 Slc20a1 NM_031148 2,1 - - -1,2
Solute carrier family 15 (oligopeptide transporter), member 1 Slc15a1 NM_057121 2,0 1,5 1,6 0,9
Transporter 1, ATP-binding cassette, sub-family B Mdr/Tap1 NM_032055 - 1,8 2,8 1,4
Oxidative stress
Dual oxidase 2 Duox2 NM_024141 1,9 2,4 2,8 1,6
Glutathione peroxidase 2 Gpx2 NM_183403 - 2,3 3,0 2,2
Xanthine dehydrogenase Xdh NM_017154 - 1,8 2,5 1,4
Immune response
Rat class III Fc-gamma receptor Fcgr3 M64368 2,1 1,6 - ND
Immunoglobulin superfamily, member 4 Igsf4d XM_340958 2,1 1,6 1,4 1,1
Rat MHC class I truncated cell surface antigen RT1-Aw2 M10094 2,0 - 1,9 1,0
Interleukin enhancer-binding factor 1 Ilf1 XM_221212 2,0 1,5 - 1,1
Colony stimulating factor 2 (granulocyte-macrophage) Csf2 XM_340799 2,0 1,6 - 1,2
Interleukin 1 alpha Il1a NM_017019 1,8 2,0 2,3 1,4
Interleukin 1 beta Il1b NM_031512 - 2,1 4,0 2,6
TRAF2 binding protein T2bp NM_00101404
4
1,8 2,8 4,4 2,4
Toll-like receptor 2 Tlr2 NM_198769 - 1,5 2,3 1,3
Antimicrobial defense
Lipopolysaccharide binding protein Lbp NM_017208 1,9 1,8 2,2 1,3
Defensin 5 precursor (Enteric defensin) RD-5 XM_214386 -1,9 -1,6 -1,6 ND
Phospholipase A2, group IIA (platelets, synovial fluid) Pla2g2a NM_031598 3,4 5,2 10,5 7,3
Inflammatory response
Pancreatitis-associated protein Pap NM_053289 11,4 44,6 114,2 17,7
Tissue-type transglutaminase Tgm2 NM_019386 - 2,3 4,9 1,8
Regenerating islet-derived 3 gamma Reg3g NM_173097 - 2,3 4,3 1,9
Nitric oxide synthase 2, inducible Nos2 NM_012611 - 1,6 4,0 ND
S100 calcium binding protein A8 (calgranulin A) S100a8 NM_053822 - 1,8 2,4 1,4
Calprotectin 
S100 calcium binding protein A9 (calgranulin B) S100a9 NM_053587 - 1,7 1,9 1,3
Interferon
Interferon-induced guanylate-binding protein 1 Gbp1 XM_221883 2,4 1,9 2,2 1,3
Interferon gamma inducible protein Ifi47 NM_172019 1,7 2,7 7,3 2,6
Guanylate binding protein 2, interferon-inducible Gbp2 NM_133624 1,6 2,4 3,1 1,7
Interferon-induced protein Ifit2 NM_00102475
3
1,5 1,7 3,4 1,3
Interferon-stimulated protein G1P2 XM_216605 - 1,6 4,1 1,5
Immunity-related GTPase family, M Irgm NM_00101200
7
- 1,8 3,7 1,4
Signal transducer and activator of transcription 1 Stat1 NM_032612 - 1,7 3,6 1,8
Interferon regulatory factor 7 Irf7 XM_215121 - 1,5 2,6 ND
Alpha-interferon Ifna XM_233145 - 2,0 - ND
Proteolysis
Ubiquitin D Ubd NM_053299 1,7 2,5 15,2 3,4
Proteosome (prosome, macropain) subunit, beta type 9 Psmb9 NM_012708 - 2,0 3,7 2,0
Protease, serine, 22 Prss22 XM_220222 - 2,0 2,6 1,6
Potential ubiquitin ligase Herc6 XM_342700 - 1,7 3,3 1,5
Proteasome (prosome, macropain) subunit, beta type 10 Psmb10 XM_214687 - 1,5 2,1 1,5
aValues in bold exceed cut-off value FC > 2 or FC < -2. Values -1,5 < FC < 1,5 are indicated by (-).
b Fold Change infected vs non-infected rats fed a cellulose diet at day 2 p.i (obtained from the dietary infection study). All fold changes are shown. Genes not 
detected in this independent study are indicated by ND.
BMC Microbiology 2007, 7:84 http://www.biomedcentral.com/1471-2180/7/84not result from changes in cellular composition of the
mucosa. This is in agreement with histology results from
earlier Salmonella infection experiments, showing no or
only minor deviations in intestinal mucosal architecture
from healthy control slides (data not shown). This is fur-
ther supported by the relatively constant expression of a
group of well known housekeeping genes (Additional File
2). The largest group of related genes induced by Salmo-
nella infection in colon mucosa is related to interferon
pathways as more than 20 IFNγ-regulated genes showed
increased expression at at least one time point studied.
The IFNγ-induced gene expression was most prominent at
day 6 p.i, but already from day 1 onwards induction of
several IFNγ-inducible GTPases (Gbp1, Gbp2, Ifi47, Ifit2)
was seen (table 2). Furthermore at day 3 p.i. (table 2)
induction of two members of the IFNγ-signaling pathway
(Stat1 and Irf7) was observed. Despite induction of many
interferon-related genes, increased expression of IFNγ
mRNA itself could not be detected (changed 1.1-fold at
days 1 and 3, and 1.3-fold at day 6 p.i.). IFNγ protein con-
centrations were measured in individual serum samples.
IFNγ was not detected in serum of non-infected rats (all
timepoints) and at the first day after Salmonella adminis-
tration to rats. However, from day 3 p.i. serum IFNγ
increased (figure 3). The serum IFNγ most probably origi-
nated from peripheral immune activation, as the increase
in serum IFNγ followed the same trend as the increase in
Salmonella CFU's in peripheral organs (table 1). In the
time course infection study, the kinetics of urinary NOx
excretion are reflected by Nos2 gene expression in colonic
mucosal with a small 1.6-fold induction at day 3 p.i. and
a 4 fold induction at day 6 p.i. (table 2).
Q-PCR confirmation of Salmonella-induced gene-expression
To determine inter-individual variation in gene expres-
sion within treatment groups, RNA from the colon of
individual animals was analyzed by Q-PCR. We chose
individual confirmation of Stat1 and Ifi47 to gain insight
in inter individual interferon response as we also focused
on the individual protein levels of IFNγ. Confirmation of
PAP was chosen to obtain insight in the individual kinet-
ics of the most strongly induced gene in colon mucosa at
all time points. Q-PCR analysis showed rather large inter-
individual variation among the outbred rats. Pap expres-
sion levels in the non-infected colonic mucosa were near
detection level, which made it difficult to determine pre-
cise fold changes. Nevertheless, the Q-PCR analysis of the
three genes examined clearly confirmed the gene expres-
sion changes observed in the microarray analysis (figure
4). To further validate the array data of the time course
infection study we compared the gene expression changes
of day 1 and 3 p.i. with gene expression data obtained
from the independent dietary infection study at day 2 p.i.
(table 2). Similar biological processes were induced at
early timepoints in both studies. At individual gene
expression level several transporter genes (Cacna1i,
Slc4a1, Slc15a1) and immune response genes (Igsf4d, Ilf1,
Csf2) showed no overlap possibly due to infection kinet-
ics. However gene expression results of day 3 and day 2
p.i. largely overlapped (table 2).
Dietary infection study
General infection characteristics
Food consumption and growth of the Wistar rats on both
cellulose and FOS diet were similar, before and after infec-
tion. The section was performed on day 2 p.i. because sim-
ilar effects on gene expression at days 1 and 3 were
observed in the time course infection study. Furthermore
we were interested in the primary responses as we expect
that diet will mainly influence early events such as attach-
ment to the mucosa and translocation of the pathogen.
These events occur for the most part luminal where direct
interaction between dietary components, pathogens and
mucosa take place, while later phases merely reflect sec-
ondary infection and inflammation responses. At day 3
p.i. the serum IFNγ concentration and the amount of
translocated Salmonella in the spleen are already high,
which indicates systemic infection. At day 1 p.i. no serum
IFNγ or Salmonella translocation to the spleen was
observed. We chose day 2 p.i. as this seems the appropri-
ate time point to study the effects of FOS on early Salmo-
nella-induced changes. Salmonella colonization was
quantified by determination of colony-forming units
(CFU/g) in fresh fecal samples with time. At day 1 Salmo-
nella levels were not significantly different between cellu-
lose and FOS-fed animals (7.23 ± 0.11 and 7.10 ± 0.22,
respectively). At day 2 FOS-fed rats had more Salmonella in
feces than their cellulose counterparts (7.25 ± 0.25 and
Serum IFNγ levels before and after infection (days 1, 3 and 6 p.i.)Fig re 3
Serum IFNγ levels before and after infection (days 1, 3 and 6 
p.i.). Each dot represents an individual rat. Group medians 
are presented by a black line. * p < 0.05, ***p < 0.001.
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BMC Microbiology 2007, 7:84 http://www.biomedcentral.com/1471-2180/7/846.53 ± 0.25, respectively; p < 0.05). Salmonella transloca-
tion to mesenteric lymph nodes and spleen was not signif-
icantly different in the FOS group compared to the
cellulose group when quantified by CFU. Viable Salmo-
nella counts in MLN were 5.96 ± 0.08 in the cellulose
group and 6.19 ± 0.10 log10 CFU/g in the FOS group.
Numbers in spleen were 2.85 ± 0.14 (cellulose) and 2.98
± 0.16 log10 CFU/g (FOS). Counts in liver were under the
detection limit of 102 CFU/g tissue in the cellulose and
FOS group. These numbers are comparable to those
observed in the time course infection study at day 3 and
highly similar to numbers observed in earlier studies
which showed increased translocation in FOS-fed rats at
later time points after infection [23]. To observe long term
effects of FOS on Salmonella translocation in this study,
urinary NOx excretion with time was determined in addi-
tional groups of rats. Urinary NOx excretion of FOS-fed
rats increased to 132 µmol/d at day 6 p.i. and started to
decline towards baseline levels thereafter (figure 1B). Peak
urinary NOx excretion of infected rats fed the cellulose
diet was just one third of the level reached by the infected
rats fed the FOS diet, i.e. 41 µmol/day (figure 1B). The
NOx values for the cellulose diet are similar to those
obtained in the time course infection study (figure 1A).
The kinetics of urinary NOx excretion were similar in both
diet groups, but total infection-induced urinary NOx
excretion was higher in the FOS group indicating
enhanced Salmonella translocation.
Effect of dietary FOS on Salmonella-induced mucosal genes in colon 
mucosa
The rats of the time course infection study and the rats in
the dietary infection study on cellulose diet showed a
comparable urinary NOx excretion and thus Salmonella
translocation response. Despite the fact that the two stud-
ies were separately performed and different time points
were studied, the identified biological processes affected
by Salmonella at day two p.i. were comparable to processes
observed at days 1 and 3 p.i. Furthermore both studies
showed that more genes were up-regulated than down-
regulated by Salmonella. For detailed analysis, we focused
on the most robust genes, i.e. genes that showed similar
Salmonella induced regulation in the two independent
studies. We choose a threshold of FC < 1.5 for both stud-
ies, which is less stringent than the threshold we choose
for analysis within one study (FC < 2.0). We feel that this
is legitimate, as genes with small but similar regulation in
two completely independent studies are less likely to be
selected by chance. Thirty-one genes fulfilled this crite-
rion, 26 were up-regulated and 5 down-regulated. Eight-
een of the up-regulated genes were categorized to the
same processes found to be modulated by Salmonella in
the colonic mucosa in the time course infection study, i.e.
the transporter Clca6, the oxidative stress genes Gpx2 and
Duox2, the immune response genes Il1b and T2bp, the
Individual expression of two interferon-related genes and Pap i  the co on mucosa at different time points after Salmonella fection r contr l treatmentFigure 4
Individual expression of two interferon-related genes and Pap 
in the colon mucosa at different time points after Salmonella 
infection or control treatment. Genes expression is quanti-
fied by Q-PCR, using Rps26 as reference gene (using Arf1 as 
reference gene showed similar results; data not shown). Each 
dot represents an individual rat. Dotted line indicate lowest 
mRNA standard. Medians are presented by a black line. The 
median value of the uninfected group was set at 1.0. Y-axis is 
at log10 scale. * p < 0.05, **p < 0.01, ***p < 0.001.
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BMC Microbiology 2007, 7:84 http://www.biomedcentral.com/1471-2180/7/84antimicrobial defense gene Pla2g2a the inflammatory
response genes Pap, Tgm2 and Reg3g, the interferon related
genes Ifi47, Gbp2, Iigp2, P47Iigp, Stat1, G1p2 and the pro-
teasome related genes Psmb9, Prss22, Psmb10, Ubd (Table
2). The other 8 up-regulated genes which could not be
grouped to a specific process were Palmitoyl-protein
thioesterase, Schlafen 3 (Slfn3), Tripartite motif protein
15 (Trim15), Aquaporin 3 (Aqp3) and four unknown
genes. The 5 down-regulated genes were Heat shock pro-
tein 70 kD 1A (Hspa1a), Resistin like alpha (Retnla), Resis-
tin like gamma (Retnlg), Collectin sub-family member 10
(Colec 10) and Mammalian suppressor of Sec4 (Mss4).
Not all processes that were identified in the time course
infection study at both days 1 and 3 p.i. were confirmed
in the dietary infection study at day 2 p.i. (table 2). This
was the case for two processes, namely transport (Cacna1i,
Slc4a1, Atp12a, Slc15a1) and immune response (Igsf4d,
RT1, Ilf1, Csf2, Il1a). Furthermore the antimicrobial
defense gene Lbp and two interferon pathway genes
(Gbp1, Ifit2) were not confirmed.
To examine whether our choice for FC > 1.5 was legiti-
mate, we studied whether application of threshold FC >
1.3 and FC > 1.7 resulted in identification of the same
processes as identified with FC > 1.5. The general picture
of processes affected was the same for FC > 1.5 and FC >
1.7. However, with FC > 1.3 more genes could be included
in processes identified with FC > 1.5, such as the inter-
feron response and proteolysis (data not shown). How-
ever, many other genes could not be grouped into (new)
specific biological processes, indicating that a cut-off FC >
1.3 might be too flexible and results in introduction of
false positive processes, probably not related to the treat-
ment. Therefore, we choose FC > 1.5 for further analysis.
To investigate the effects of FOS on Salmonella infection in
the colon, we studied the expression of Salmonella-
induced colonic mucosal genes in infected rats fed the cel-
lulose diet versus infected rats fed the FOS supplemented
diet. The five genes that were consistently downregulated
by Salmonella in both studies (Hspa1a, Retnla, Retnlg, Colec
10 and Mss4) were not further influenced by FOS (equal
gene expression in cellulose- and FOS-fed infected rats).
For initiating early mucosal events after Salmonella infec-
tion (e.g. chemo attraction of inflammatory cells)
increases in epithelial gene expression may be more
important than decreases[24,25]. We focused on the 26
genes which showed a consistent increase in gene expres-
sion after Salmonella infection of FC > 1.5 in both studies.
All 26 genes consistently induced by Salmonella infection
in the colon mucosa showed a further up-regulation in
colon mucosa of Salmonella infected rats fed FOS (figure
5). The effect of FOS on the cluster of Salmonella affected
genes was statistically significant. To asses the inter-indi-
vidual gene expression in the dietary infection study we
selected genes from several Salmonella modulated process
for individual Q-PCR confirmation: Clca6, Gpx2, Il1b,
Pla2g2a, Pap, Tgm2, Stat1, Gbp2 and Ifi47. Q-PCR of the
selected genes in individual samples showed high inter-
individual variation but confirmed the fold changes of the
microarray study using pooled samples (table 3). The con-
firmed Salmonella induced gene expression changes were
significant (p < 0.05) for 7 of the 9 genes, except for Tgm2
(p = 0.09) and Stat1 (p = 0.08). Examination of FOS-fed
versus cellulose-fed infected groups on individual gene
level showed a significant increase of Clca6 and Pla2g2a.
Expression of Gpx2, Il1β and Tgm2 was >1.5-fold
increased by FOS feeding in comparison to cellulose feed-
ing but this was not statistically significant. The genes Pap,
Stat1, Ifi47 and Gbp2 showed non-significant and small
increases of 1.1–1.4 fold. In t-testing each gene is tested
independently, the FOS vs cellulose effect was not statisti-
cally significant for each independent gene. However, FOS
significantly increased expression of the cluster of the 26
Salmonella induced genes (see figure 5 and Additional
File 3). We also looked at overall gene expression differ-
ences between cellulose- and FOS-fed rats at day 2 after
Salmonella infection (Additional File 3). This was done to
determine whether the stimulated translocation in FOS-
fed rats resulted in additionally affected genes or biologi-
cal processes not induced by Salmonella in the cellulose
groups. Twenty genes were induced by Salmonella >2-fold
in cellulose-fed infected rats. In the FOS-fed infected rats
72 genes were induced by Salmonella >2-fold. Seventeen
Expression level of most consistent Salmonella-target genes in colon mucosa of rats fed a cellulose diet or  FOS dietFigure 5
Expression level of most consistent Salmonella-target genes in 
colon mucosa of rats fed a cellulose diet or a FOS diet. The 
gene expression is obtained from micro array analysis of 
pooled colonic mucosa samples collected at day 2 post-infec-
tion. Each dot represents a gene. The median value of each 
gene in the uninfected group is set to 1.0. Y-axis is at 
log2scale. ***p < 0.001.
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analysis of the genes exclusively induced (>2-fold) in the
FOS-fed group showed that those could be categorized in
the same processes identified earlier (table 2 and Addi-
tional File 3). Obviously, the induced translocation of Sal-
monella by FOS supplementation did not affect other
processes than those already identified in Salmonella
infected rats on a cellulose diet. However, more genes of
the same processes and higher fold-changes were noticed
in the colonic mucosa of infected rats on the FOS diet.
Nos2 gene expression in colonic mucosa was below detec-
tion levels in the dietary infection study. As significant dif-
ferences in NOx excretion between infected cellulose- and
FOS-fed rats were observed from day 5, no differences at
Nos2 gene expression were expected at day 2 p.i. Serum
IFNγ was not detected at day 2 p.i., neither in infected cel-
lulose-fed rats nor in infected FOS-fed rats.
Discussion
Colon is an infection target
This study shows quick and profound gene expression
changes in the rat colon mucosa upon oral S. enteritidis
infection, which implicates that not only the ileum, but
also the colon, is a target for Salmonella infection. The ear-
liest responses were noticed on mucosal transport and
antimicrobial defense. The most responsive gene is Pap,
which showed an 11-fold induction in colon mucosa on
the first day after infection and increased to over 100 fold
at day 6. At later timepoints, the most notable process
affected is interferon-related. Colonic genes consistently
induced by Salmonella infection in two independent stud-
ies, were all further enhanced by FOS supplementation, a
known stimulus of colonic bacterial fermentation. Salmo-
nella, ingested with contaminated foods or drinks, is
thought to colonize the distal small intestine and to trans-
locate through ileal Peyer's patches to extra-intestinal
organs [4,26]. Several observations suggest that other
parts of the intestine are also involved in Salmonella infec-
tion. High numbers of Salmonella are found in the cecum
and colon of orally infected rats [4,26] as well as pigs [27].
In humans Salmonella commonly affects the small intes-
tine, but colonic involvement of S. enteritidis has been
reported in humans [6,7,28] and may play an important
role in induction of diarrhea [6]. Studies describing
mucosal invasion via the paracellular and transcellular
route [29,30] also suggest that translocation of Salmonella
species to the systemic circulation is not restricted to the
ileal Peyer's patches. Our studies on the effects of prebiot-
ics on resistance of the host to Salmonella infection also
point to the colon as invasion site [11]. Together results
from literature and those presented here indicate that the
colon is one of the targets for Salmonella infection.
Interferon-gamma response
The increase of many IFNγ-regulated genes in the Salmo-
nella-infected colon in the present in vivo study actually
confirms the earlier suggested role of IFNγ in relation to
host defense against Salmonella. Serum IFNγ levels
increase in mice infected with Salmonella by oral or intra-
peritoneal route [31-34]. IFNγ is produced by natural
killer cells, CD4 Th1 cells and CD8 cytotoxic lymphocytes
[35-37]. IFNγ most likely exerts its function in host
defense by activation of macrophages which can kill Sal-
monella [38]. In our Salmonella time course infection
study, more than 20 IFNγ-related genes were up-regulated
(table 2). This did not coincide with an increased IFNγ
mRNA level at any of the time points studied. In addition,
we could not detect IFNγ protein in Salmonella-infected
colons (data not shown). Serum levels of this pro-inflam-
matory cytokine were undetectable at day 1 p.i. but rose
steadily from day 3 p.i. with large inter-individual varia-
tion in the magnitude of response (figure 3). Despite the
lack of detectable IFNγ protein in colonic mucosa and in
serum at day 1, we did observe increased expression of
genes in the INFγ induced pathway at that timepoint.
These genes are most likely activated by INFγ [39]. We can
not fully exclude that dilution of IFNγ-producing cells in
the heterogeneous cell population of mucosal scrapings
has lead to undetectable levels of this regulatory cytokine
in the present study. At the later timepoints, serum IFNγ is
strongly increased, whereas mucosal IFNγ remained
below detection levels at all timepoints. This may suggest
that systemic rather than colonic IFNγ seems to be the trig-
ger for the later activation of IFNγ-related genes and -proc-
esses in colonic mucosa upon Salmonella infection.
However, dilution of IFNγ producing cells in colonic tis-
Table 3: Q-PCR analysis of Salmonella -induced colonic mucosal 
gene expression of rats on a cellulose or a FOS diet (day 2 p.i.)
Relative gene expression a
Non-
infected b
Infected
Gene symbol Cellulose FOS
Clca6 1 (0.9–1.3) 1.6 (1.4–2.2) 3.7 (2.8–4.1)
Pla2g2a 1 (0.8–1.3) 4.6 (2.3–7.1) 8.8 (6.1–21.1)
Gpx2 1 (0.8–1.2) 2.1 (1.7–2.4) 3.2 (1.3–4.8)
Il1b 1 (0.6–1.1) 2.0 (1.3–3.4) 3.8 (0.6–5.4)
Tgm2 1 (0.5–1.2) 1.6 (0.7–4.4) 10.2 (0.8–20.6)
Pap 1 (0.4–2.4) 236 (68–326) 288 (13–1162)
Stat1 1 (0.7–1.2) 1.2 (1.1–2.2) 1.5 (0.7–4.0)
Ifi47 1 (0.8–1.2) 3.9 (2.1–6.4) 5.6 (1.6–18.4)
Gbp2 1 (0.8–1.4) 2.0 (1.1–3.2) 2.1 (0.5–9.7)
aThe expression of genes is analyzed by QPCR, using Rps26 as 
reference gene (using Arf1 as reference gene gave similar results; data 
not shown). Data are represented as median (25% percentile–75% 
percentile).
bThe median value of the non-infected group is set to 1.0.Page 8 of 16
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time point.
As many as 1200 genes are known to be regulated by IFNγ.
Their gene products are mediators of the immune
response essential for host defense against pathogens.
One group of clearly regulated IFNγ-induced genes is the
GTPase family, which modulates survival of pathogens
residing in phagosomes or vacuoles [39,40]. They are
defined into three classes: Guanylate-binding proteins
(Gbp's), the p47 GTPases and the Mx proteins. We found
Salmonella-induced up-regulation of the first and second
group, i.e. Gbp1, Ifi47, Gbp2, Iigp and Irgm (Table 2). IFNγ
induces expression of p47 GTPases via activation of Stat1
which was also increased by Salmonella at days 2 and 3 p.i.
Mutant mice with gene disruptions in IFNγ or Stat1 are
significantly compromised in their immune response to
microbial infections, including salmonellosis [41]. Thus
the increased expression of IFNγ-related genes in colonic
mucosa in the present study confirms the earlier proposed
role of this cytokine in Salmonella infection.
Pancreatits associated protein
The colonic mucosal gene most highly induced by Salmo-
nella infection on the array was Pap, which was confirmed
by Q-PCR of individual rat samples. PAP is a member of
the Reg III gene family, which includes Regenerating islet-
derived 3 gamma (Reg3g) which was also increased in our
study. Pap expression is also increased in the rat ileal
mucosa infected with S. enteritidis [3] and in the gastroin-
testinal tract of pigs infected with Salmonella typimurium
[42]. Furthermore, significant up-regulation of intestinal
mucosal Pap expression is described in IBD patients,
whose bowel is chronically inflamed [43-45]. This sug-
gests that PAP is a marker for acute as well as chronic
inflammation. Biological functions of PAP in the intestine
are not fully uncovered. Recently, it was proposed to func-
tion in innate immunity [44,46]. PAP was shown to have
direct antimicrobial properties as it was able to bind and
kill Gram-positive bacteria, but not Gram-negative Salmo-
nella typhimurium [46]. Additional research will be needed
to answer whether PAP is able to inhibit the growth of Sal-
monella enteritidis. Pap and Reg3g are expressed in several
tissues and organs, but the small intestine has the highest
expression under normal conditions. Only very low levels
can be found in colon [47]. Indeed, Pap mRNA expression
for most non-infected rats was below detection level (fig-
ure 4). Three rats did not express Pap at timepoint day 3
p.i. (figure 4), whereas at day 6 p.i. all rats expressed
increased levels of Pap. Variation in infection kinetics
between (outbred) rats is obviously reflected in Pap
expression. We are currently investigating which mucosal
cell types contain PAP and whether it is secreted to the
intestinal lumen or to the serosal (blood) site. If secreted,
PAP might be used as a non-specific marker to follow and
quantify intestinal infection or inflammation in humans.
Calprotectin
Calprotectin (S100a8/a9), a heterodimer of the two cal-
cium-binding proteins S100A8 and S100A9, was up-regu-
lated in the colonic mucosa by Salmonella (Table 2). Both
subunits were increased in colon. Calprotectin is a 36 kDa
calcium and zinc binding protein and constitutes approx-
imately 60% of soluble cytosolic proteins in neutrophil
granulocytes. Therefore, calprotectin is a marker of neu-
trophil influx and is elevated in a number of inflamma-
tory conditions. In agreement with our results, Naughton
et al (1996) also found increased levels of this marker in
Salmonella-infected animals. Fecal calprotectin is emerg-
ing as a useful marker to quantify mucosal inflammation,
not in the least because it appears to be stable in feces
which can be obtained by non-invasive means [48].
Differences between colon and ileum
Ileum and colon are both targets for Salmonella. Remarka-
bly, the number of genes showing increased expression is
larger than the number of genes showing decreased
expression upon Salmonella infection in both ileum and
colon. However, this is more extreme in colon than in
ileum mucosa [5]. Technical bias is unlikely as in a flavo-
noid intervention study with rats and using the same array
system and data handling the number of down-regulated
genes was similar to the number of up-regulated genes
[49]. In an in vivo Salmonella infection study in pigs only
up-regulated and no down-regulated genes were observed
[42].
The extent of the early response to Salmonella is similar for
both intestinal segments: From all genes expressed above
background level on the arrays, 0.21% of the genes
expressed in the colon and 0.26% of genes expressed in
the ileum [5] were affected at day 1 p.i. The colonic
response is less than the ileal response at day 3 p.i., as
0.15% of colonic mucosal genes were affected versus
0.67% of ileal mucosal genes. The smaller colonic
response could be due to differences in crypt-villus archi-
tecture of the ileal and colonic mucosa. Furthermore, the
colonic mucosa, which is constitutively exposed to bacte-
ria, might be more efficient in repressing host- or more
specifically immunological responses to bacteria, includ-
ing pathogens [50-52].
Ileum and colon show overlapping as well as distinct
processes affected upon oral infection [5]. At early time
points after oral infection i.e. transport processes and anti-
microbial defenses were regulated in both intestinal seg-
ments, but the process-related genes did not fully overlap.
At day 1 p.i., glucose transporters were increased in the
ileum, whereas in colon ion transporters were induced.Page 9 of 16
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involvement of the distal part of the gut in diarrhea devel-
opment during salmonellosis as reported earlier in
humans [6]. The gene coding for antimicrobial defensin 5
was down-regulated by Salmonella in both ileum and
colon. Other genes coding for antimicrobial proteins
(Pla2g2a and lysozym) were clearly enhanced in the
infected colon in contrast to ileal tissue [5]. At day 3 and
6 p.i. Salmonella reduced the expression of several phase I
and II detoxification genes in the ileum, which was not
observed in the colon. The downregulation of cytochrome
P450 genes in ileum coincided with increased expression
of inflammatory genes. It is known that inflammatory
mediators can down-regulate cytochrome P450 genes
[5,53,54]. This might suggest that the inflammatory
response induced by Salmonella in colon, at later time-
points, is smaller than in ileum. Nevertheless, both tissues
showed signs of an inflammatory response at later time-
points, but responsible genes were not the same. Mainly
cytokines and chemokines were induced in the ileum,
whereas in colon many interferon-related genes were up-
regulated. No interferon response was observed in the
ileum. Apparently, the immune response in the two intes-
tinal segments is differentially regulated.
Finally, the in vivo transcriptional response of intact
mucosa to invasion by Salmonella is represented by a lim-
ited number of regulated genes compared to in vitro stud-
ies with HT-29 cells [24]. In vitro models provide insight
in complex mechanisms of Salmonella-host interaction.
However, results should be interpreted with caution as in
vitro systems show massive cell death at 24 hours, whereas
only minor inflammatory changes are observed in the
intestine 24 hours after infection with Salmonella in vivo
[55]. Several genes like Toll like receptors, Nf-κb or Il-8
that are regulated by Salmonella in vitro, were not found to
be regulated by Salmonella infection in the present in vivo
study. Possibly, transcription of these genes is highly spe-
cific for particular cell types in the colonic mucosa. Iden-
tification of cell type-specific responses of potential target
cells could be addressed in vivo using laser microdissec-
tion.
FOS and mucosal barrier function
We consistently observed that diets supplemented with
rapidly-fermentable prebiotics (such as FOS) increased
translocation of S. enteritidis in rat infection studies
despite stimulation of Bifidobacteria and Lactobacilli [23].
In other words, FOS decreases the resistance of the rat
intestinal mucosa to intestinal pathogens. Because fer-
mentation of FOS hardly occurs in the ileum of humans
[14] and rats [15], it is unlikely that prebiotics facilitated
translocation of Salmonella in the ileum. This is supported
by the absence of ileal inflammation in FOS-fed and Sal-
monella-infected rats in contrast to profound cecal and
colonic inflammation [11] The precise mechanism under-
lying the effects of FOS on the colon mucosa is not
known. FOS itself, the changed intestinal microflora or its
fermentation products (e.g. SCFA) could play a role. Preb-
iotics, such as FOS resist enzymatic hydrolysis by digestive
enzymes secreted in the small intestine and reach the
colon intact. The resident colonic microflora ferments
these carbohydrates to lactic acid and short-chain fatty
acids (SCFA). This results in lowering of the pH of intesti-
nal contents and stimulation of e.g. Bifidobacteria and
Lactobacilli [23,56]. These lactic acid bacteria are assumed
to enhance resistance [12] but we found opposite effects
[11,23]. As shown earlier, dietary FOS increases intestinal
permeability in non-infected rats and even more in
infected rats [13]. At present it is unknown whether intes-
tinal permeability is increased in ileum or colon, nor
whether it is induced by the presence of FOS or by its fer-
mentation metabolites. It has been shown that SCFA can
induce colonic mucosal injury and increase permeability
[10]. Furthermore, in vitro studies showed that SCFA can
enhance expression of virulence (e.g. invasion) genes of
Salmonella typhimurium [57,58], but data on in vivo con-
sequences have not been reported. Preliminary experi-
ments of our lab showed no evidence for increased
expression of virulence genes of Salmonella enteritidis in
infected rats fed a FOS-diet (unpublished results).
From two independent rat infection studies we identified
26 colonic mucosal genes consistently affected by Salmo-
nella. These 'robust' Salmonella target genes were all further
induced by the FOS diet. The pronounced effects of FOS
on Salmonella translocation were reflected by a modest but
highly consistent increase of all Salmonella target genes.
Moreover, the total number of genes induced by Salmo-
nella is nearly 3 times higher in FOS-fed rats than in cellu-
lose-fed rats. However, biological processes identified to
be affected by Salmonella in colon of FOS-fed rats were not
different from those observed in cellulose-fed rats. So, the
quality of the colonic response was the same, but clearly
the magnitude of the response was increased by FOS feed-
ing. Based on the physiological effects, larger gene expres-
sion differences might have been expected. The modest
responses observed might be due to our focus on Salmo-
nella-induced gene expression. It can not be totally
excluded that FOS targets other genes and processes
related to barrier function (in absence of infection) than
Salmonella. However, the genes affected by Salmonella in
FOS-fed rats did not show involvement of additional
processes in comparison to their cellulose-fed counter-
parts. In our view, the enhanced expression of colonic Sal-
monella target genes in FOS-fed animals concomitant with
stimulated translocation of this invasive pathogen indi-
cates that infection and related inflammation is worsened
by FOS supplementation. Histological analyses of intesti-
nal samples from previous FOS intervention studies ofPage 10 of 16
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inflammation in non-infected FOS-fed rats in contrast to
post-infection samples (data not shown). Therefore, we
feel that the observed aggravation of the intestinal
response is due to interaction of FOS and Salmonella.
It should be stressed, that genes identified as Salmonella
target genes in the present study are not necessarily Salmo-
nella specific, but may well result from colonic inflamma-
tion in general and thus be similar in other enteric
infections. Furthermore, effects of dietary FOS on gut bar-
rier function may not be restricted to changes in mRNA
expression, but exist on the translational or functional
level of proteins. For instance, internalization of the tight-
junction proteins occludin, claudin and junctional adhe-
sion molecule-A, caused by IFNγ, results in profound
mucosal barrier changes [59]. This cellular translocation
can occur without concomitant changes in mRNA gene
expression. Detection of such effects would require a dif-
ferent approach from transcriptomics. Many studies
report on possible therapeutic effects of FOS on intestinal
disease such as IBD and pathogenic infection. In addition
to an increase in ''beneficial" bacteria, the potential bene-
ficial effects of FOS are based on the effects on surrogate
markers, e.g. increase of mucin production [60], increase
of the size and cytokine production of Peyer's patches and
increased faecal or ileal IgA [61-63]. Changes in these
markers are often presumed to reflect increased barrier
function or resistance to pathogenic bacteria, but concom-
itant actual measurements of these functional effects are
missing. In our study, genes involved in antimicrobial
defense, immune response and inflammation were all
induced by Salmonella infection and further enhanced by
dietary FOS, but concomitantly translocation of Salmo-
nella was evident and stimulated by FOS. Therefore, these
surrogate markers should be interpreted with caution and
always correlated with functional effects or clinical end-
points.
In this study we compared Salmonella-induced gene
expression changes of two independent rat infection
experiments at early time points after oral infection. The
gene expression results were analyzed at two levels, at the
level of gene expression itself and at the level of biological
processes. Analysis at the level of gene expression showed
some variation in the expression of individual genes
between the two studies (table 2, Additional File 3). This
variation between two studies can be due to the different
time-points studied and the use of outbred rats showing
inter-individual differences in infection kinetics. Rats did
not all respond to Salmonella at the same time p.i. which
is e.g. shown by individual gene expression levels of PAP
(figure 4) and by serum IFNγ levels (figure 3). Variation in
infection kinetics and inter-individual variation are
expected features of infection studies in outbred species
[64]. It can be argued that differences between studies,
due to differences in time points measured or infection
kinetics, will result in more pronounced variance at the
level of individual genes than at the level of physiological
processes [65,66]. Indeed, analysis of gene expression at
the level of biological processes showed that both studies
gave highly comparable Salmonella-induced effects at early
time points.
In the dietary infection study, we were interested whether
the FOS-stimulated Salmonella translocation was reflected
in colonic gene expression changes. We observed an over-
lap in gene expression changes observed in the two exper-
imental diets, and an additional set of 58 genes which
were only significantly affected in the FOS-fed rats.
Although the list of altered genes was different in FOS fed
rats, this was not the case at the process level as exactly the
same processes were observed for both dietary groups.
This indicates involvement of similar underlying biologi-
cal processes in cellulose and FOS-fed infected rats and no
obvious role for other processes.
Comparison at the level of biological processes is a pow-
erful tool to interpret microarray experiments and enables
comparison of different microarray datasets [67]. Com-
parison at gene level has some drawbacks, one is redun-
dancy in gene function, which means that different genes
can provide the same physiological effect. In addition, the
homeostatic condition as well as the precise nature of the
stimulus will determine how individual genes within a
process are controlled to provide the necessary physiolog-
ical response. Differences in responses of individual genes
are filtered out when they are analyzed at the level of path-
ways or processes. However, the translation of differen-
tially expressed genes into biological processes also suffers
from limitations [68]. The most important limitation is
that annotations to pathways and processes are incom-
plete. Therefore it is important that results from pathway
analysis are manually supplemented with the remaining
significant genes using biological databases and scientific
literature.
Conclusion
In conclusion, our results show that, in addition to the
ileum, the colon mucosa is clearly a target for Salmonella
infection. Early Salmonella-induced changes were
observed in transport and oxidative stress, while at later
stage, most likely secondary, infection and inflammation
responses were observed. Some findings confirm expected
results, such as induction of an immune and inflamma-
tory response. However, the Salmonella-induced immune
response in colon is clearly different from that in ileum.
We newly identified that colonic transport processes and
proteolysis are affected by Salmonella infection and thatPage 11 of 16
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gene in Salmonella infected rat colon.
An important observation is that FOS-stimulated Salmo-
nella translocation (as measured by urinary NOx), does
not induce other processes than those observed in cellu-
lose-fed and Salmonella infected rats. So, the quality or
diversity of the colonic host response to Salmonella is not
affected by colonic FOS fermentation in contrast to the
magnitude of response. As far as we know, there are no lit-
erature data pointing to a functional effect of FOS in the
ileum. Therefore, the FOS effects on Salmonella transloca-
tion are most likely due to colonic effects. Understanding
the changes caused by FOS alone may provide insight in
processes that ultimately result in the observed weakening
of the barrier.
Methods
Time course infection study
Animals, diet and infection
The experimental protocols were approved by the animal
welfare committee of Wageningen University (Wagenin-
gen, the Netherlands). Specific pathogen-free male out-
bred 9 weeks old Wister rats (WU, Harlan, Horst, the
Netherlands, n = 48 in total), were housed individually in
metabolic cages. All animals were kept in a temperature
(22–24°C) and humidity (50–60%) controlled room
with a 12 h light/dark cycle (lights on from 6 AM to 6 PM).
Rats were fed a purified diet during the whole experimen-
tal period. The diet contained (per kg) 200 g acid casein,
502 g glucose, 160 g palm oil, 40 g corn oil, 50 g cellulose,
35 g mineral mix (without calcium) and 10 g vitamin mix
according to AIN93 recommendations [69]. Diets were
low in calcium content (20 mmol CaHPO4.2H2O/kg) and
high in fat content (200 g fat/kg)[16] to mimic the com-
position of a Western human diet. Food and demineral-
ized drinking water were supplied ad libitum. The animals
were acclimatized to the housing and dietary condition
for 11 days, after which they were orally infected with S.
enteritidis (clinical isolate, phage type 4 according to inter-
national standards; B1214 culture of NIZO food research,
Ede, the Netherlands). Salmonella infection was per-
formed by gastric gavage with 1 mL of saline containing 3
× 109 colony forming units (CFU) of S. enteritidis. Non-
infected rats received saline only (control). S. enteritidis
was cultured and stored, as described earlier [23]. Fresh
fecal samples were collected on days 1, 2, 3 and 6 post
infection (p.i.) and analyzed for viable Salmonella by plat-
ing 10-fold dilutions in sterile saline on Modified Brilliant
Green Agar (Oxoid, Basingstoke, UK) and incubating aer-
obically overnight at 37°C. Sulphamandelate (Oxoid)
was added to the agar plates to suppress swarming bacte-
ria, such as Proteus species. The detection limit of this
method was 102 CFU/g fecal wet weight. Total 24 h urine
samples were collected from the day before oral infection
of the rats until day 6 after infection. Urines were pre-
served by adding oxytetracycline to the urine collection
vessels of the metabolic cages, and analyzed for the nitric
oxide metabolites nitrite and nitrate (summed as NOx) by
a colorimetric method (Nr. 1746081; Roche diagnostics,
Mannheim, Germany).
Rats were sacrificed on day 1, 3 or 6 post infection and
control (n = 8 rats per treatment and per time point). Rats
were killed by carbon dioxide inhalation. Blood was col-
lected by orbita puncture. Blood was coagulated for 30
minutes at room temperature, cooled to 4°C and centri-
fuged 20 minutes by 3000 g. Serum was collected and fro-
zen at -80°C. The mesenteric lymph nodes (MLN), spleen
and liver were excised aseptically, weighed, homogenized
(Ultraturrax Pro200, Pro Scientific Inc. Oxford, CT) in
sterile saline, serially diluted, and plated to culture for Sal-
monella, as described above. The detection limit was 102
CFU/g tissue. To obtain colonic mucosa, the colon was
taken out, longitudinally opened and colonic contents
removed by a quick rinse in 154 mM KCl. The mucosa was
scraped off using a spatula. The scrapings were immedi-
ately frozen in liquid nitrogen and stored at -80°C for
RNA extraction.
RNA isolation
Colon scrapings were homogenized in liquid N2 using a
mortar and pestle cooled with liquid N2.(Fisher Emergo,
Landsmeer, The Netherlands). Total RNA was isolated
from these homogenates using TRIzol reagent (Invitro-
gen, San Diego, CA) according to the manufacturer's
instructions. Total RNA was purified using Rneasy col-
umns (Qiagen, Chatsworth, CA). Absence of RNA degra-
dation was checked on a 1% TBE/agarose gel after 1 hour
incubation at 37°C. The purity and concentration were
measured with the Nanodrop (Isogen Life Science, Maars-
sen, The Netherlands). OD A260/A280 ratios were all
between 2.08 and 2.10 indicating RNA of high purity.
Analysis of mRNA expression by Oligo Arrays
For microarray hybridization, equal amounts of RNA of
each animal were pooled per treatment group. Arrays were
performed in duplicate. For this, RNA pools were split and
separately reverse transcribed and labeled with Cy-5. A
standard reference sample, consisting of a pool of all
colonic RNA was labeled with Cy-3. For each oligo array,
35 µg of total RNA was used to make Cy-5 or Cy-3 labeled
cDNA. Total RNA was mixed with 4 µg T21 primer, heated
at 65°C for 3 min (RNA denaturation) followed by 25°C
for 10 min (primer annealing). cDNA was synthesized by
adding 5× first strand buffer (Invitrogen), 10 mM DTT, 0.5
mM dATP, 0.5 mM dGTP, 0.5 mM dTTP, 0.04 mM dCTP,
0.04 mM Cy5-dCTP or Cy3-dCTP, 1.2 U RnaseOUT and 6
U SuperScript II Reverse Transcriptase to a total volume of
62.5 µL. The reaction was incubated at 42°C for 2 h. Puri-Page 12 of 16
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cDNA were performed as described earlier [70].
The 44 K rat whole genome Agilent array (G4131A, Agi-
lent Technologies, Inc. Santa Clara, CA) used consists of
44290 60-mer rat oligonucleotides, including ~ 3000 con-
trol spots. The Cy5 labeled cDNAs of the Salmonella
infected groups and the non-infected groups were mixed
1:1 with the Cy3 reference labeled cDNA, mixed with 2×
hybridization buffer (Agilent Technologies) and 10× con-
trol targets (Agilent Technologies) and hybridized for 17
hours at 60°C in Agilent hybridization chambers in an
Agilent hybridization oven rotating at 4 rpm (Agilent
Technologies). After hybridization the arrays were washed
with an SSPE wash procedure (Agilent Technologies) and
scanned with an Agilent Microarray Scanner (Agilent
Technologies).
Data analysis
Signal intensities for each spot were quantified using Fea-
ture Extraction 8.1 (Agilent Technologies). The data of the
time course infections study are available in Additional
File 4 and have been deposited in NCBIs Gene Expression
Omnibus [71] and are accessible through GEO Series
accession number GSE7496. Median density values and
background values of each spot were extracted for both
the experimental samples (Cy5) and the reference sam-
ples (Cy3). Quality check was performed for each micro-
array using both LimmaGUI package in R from
Bioconductor [72] and Microsoft Excel. Data was exported
into GeneMaths XT (Applied Maths, Sint-Martens-Latem,
Belgium) for analysis. We discarded spots with an average
intensity, over all arrays, of Cy5 lower than 2-fold above
average background. Then, the Cy5 intensities were nor-
malized against the Cy3 reference as described before
[73]. The gene expressions of duplicate arrays were aver-
aged. Array data of non-infected rats, killed on section day
1 and 6 were highly comparable and could therefore be
considered as one group and were averaged. For unknown
reason, arrays of non-infected rats killed on day 3 showed
reduced expression of 14 mast cell protease genes when
compared with non-infected rats of both days 1 and 6,
which were highly comparable. Therefore, we decided not
to include the non-infected rats of day 3. Cluster analysis
and Principle component analysis were performed using
GeneMaths XT. Infected/control ratio's between 0–1 were
expressed as the negative inverse (-1/value) for easier
interpretation. Genes that changed more than 2-fold in
comparison with controls at one of the time points stud-
ied were selected for pathway analysis. Pathway analysis
was performed using two pathway programs, MetaCore
(GeneGo Inc, St. Joseph, MI)[18]and ErmineJ [19], using
Agilent gene annotation (Agilent Technologies, version
20060331). Processes were identified using statistical
over-representation in both pathway programs. Since
only 40% of the genes were annotated to GO processes in
both pathway programs, processes with a p-value < 0.001
were manually supplemented with non-annotated genes
with FC > 2 using biological databases (BIOcarta,
SOURCE, GenMAPP, KEGG) and scientific literature.
Analysis of mRNA expression by Real-time Quantitative RT-PCR
Real-time Quantitative RT-PCR (Q-PCR) was performed
on individual samples (n = 8 per group). 1 µg of RNA of
all individual samples was used for the cDNA synthesis
using the iScript cDNA synthesis kit of Bio-Rad Laborato-
ries (Veenendaal, The Netherlands). Real-time reactions
were performed by means of the iQ SYBR Green Supermix
of Bio-Rad using the MyIQ single-color real-time PCR
detection system (Bio-Rad). Each reaction (25 µl) con-
tained 12.5 µl iQ SYBR green supermix, 1 µl forward
primer (10 µM), 1 µl reverse primer (10 µM), 8.5 µl
RNase-free water and 2 µl diluted cDNA. The following
cycles were performed 1× 3 min at 95°C, 40 amplification
cycles (40× 10 s 95°C, 45 s 60°C), 1× 1 min 95°C, 1× 1
min 62°C and a melting curve (80× 10 s 55°C with an
increase of 0.5°C per 10 s). A negative control without
cDNA template was run with every assay. The optimal
melting point of dsDNA (Tm) and the efficiency of the
reaction were optimized beforehand. Data were normal-
ized against the reference genes Ribosomal protein S29
(Rps29), ADP-Ribosylation Factor 1 (Arf1) and β-actin.
Rps29 and Arf1 were chosen on the basis of microarray
data which showed similar expression levels for all micro-
arrays, β-actin was chosen as this is a well accepted refer-
ence gene. Primers were designed using Beacon designer 4
(Premier Biosoft International, Palo Alto, CA). For
sequences see Additional File 5. A standard curve for all
genes including reference genes was generated using serial
dilutions of a pooled sample (cDNA from all reactions).
mRNA levels were determined from the appropriate
standard curve. Samples with mRNA levels below the low-
est standard value, and thus below detection level, were
given half the value of this lowest standard. Analysis of all
individual samples was performed in duplicate.
Serum Interferon Gamma
The serum Interferon Gamma (IFNγ) concentration of
individual rats was determined by an enzyme-linked
immunosorbent assay (ELISA) specific for rats (Biosource
International, Camarillo, CA) according to the manufac-
turer's protocol.
Dietary infection study
Animals, diet and infection
A dietary intervention was performed to study the effect of
FOS on S. enteritidis-induced gene expression. Specific
pathogen-free male outbred Wister rats (8 weeks old,
mean body weight of 253 g; n = 48 in total) were housed
as described above (time course infection study). RatsPage 13 of 16
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tal diets both contained 20 g/kg cellulose and were sup-
plemented with either 60 g/kg FOS (purity 93%; Raftilose
P95, Orafti, Tienen, Belgium) or additional 60 g/kg cellu-
lose as described earlier [23]. Animals were fed restricted
quantities (14 g/day) of the purified diet. Restricted food
intake was necessary to prevent differences in food con-
sumption and hence differences in vitamin and mineral
intake as observed earlier in FOS interventions [11]. After
an adaptation period of 14 days, rats were orally infected
with 4 × 108 CFU of S. enteritidis or control-treated as
described above. On day 2 p.i., 12 infected FOS-fed rats,
12 infected rats fed the cellulose diet, and 12 control-
treated non-infected rats fed the cellulose diet were sacri-
ficed to obtain colonic mucosal RNA. Two additional
groups of rats fed either FOS (n = 6) or the cellulose diet
(n = 6) and infected with Salmonella were kept until day 8
p.i. for determination of urinary NOx excretion in time as
described above.
Analysis of mRNA expression by Oligo Arrays and Real-time 
Quantitative RT-PCR
RNA isolation and analysis of mRNA expression by micro-
array (pooled samples) and Q-PCR (n = 12 per treatment
group) were performed as described above. Arrays were
scanned with a Scanarray Express HT scanner (Perkin
Elmer). Signal intensities for each spot were quantified
using ArrayVision 8.0 (GE Healthcare life sciences). Data
analysis was performed as described above. The data of
the dietary infection study available in Additional File 6
and have been deposited in NCBIs Gene Expression
Omnibus [71] and are accessible through GEO Series
accession number GSE7472.
Statistical analysis
Results are expressed as median or mean depending on
normality of distribution as indicated. We used Prism 4
for all statistics (Prism 4, GraphPad software Inc., San
Diego, CA). Data was analyzed using the Student's t-test
(two-sided). Non-normally distributed data was analyzed
using the non-parametric Mann-Whitney U test (two
sided). Differences were considered statistically signifi-
cant when p < 0.05.
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